Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
News, developments and strategies related to eClinical, data management, data collection, ePRO, and more information technology used in the drug development chain. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
|
|
Study Outlines Risk Factors for Poor Outcome, Mortality Following Hip Fracture
Publish date: Mar 21, 2013
![]()
PR Newswire CHICAGO, March 21, 2013
Commencing surgery sooner may alleviate hip fracture complications
CHICAGO, March 21, 2013 /PRNewswire-USNewswire/ -- A new study,
presented today at the 2013 Annual Meeting of the American
Academy of Orthopaedic Surgeons (AAOS), identifies predictors of complications and mortality following a hip fracture,
including dialysis, cardiac disease, diabetes, and a longer time before surgery – the only modifiable risk factor when
patients are hospitalized. Each year, more than 340,000 Americans are hospitalized for hip fractures. According to AAOS data, 69 percent of hip fracture patients are female and 46 percent are
between the ages of 65 and 84. Many hip fracture patients suffer complications with life-altering consequences. The estimated
mortality rate within one year of a hip fracture ranges from 12 to 33 percent. In the study, researchers used data from the 2008 National Sample Program (NSP) of the National Trauma Data Bank (NTBD)
to identify a representative sample of 44,419 hip fractures. Among the specifics: Primary outcomes included mortality and the development of complications (4.5 percent and 12.5 percent, respectively).
Seventeen percent of patients who sustained at least one complication died. Secondary measures consisted of the development
of specific complications such as pulmonary/cardiac complications, venous thromboembolic disease and infection. Hypertension and diabetes were the most common medical comorbidities among patients. Dialysis, presenting in shock, cardiac
disease, male sex and a high Injury Severity Score (ISS) were significant predictors of mortality. Dialysis, shock, obesity,
cardiac disease, diabetes and a greater time to surgery significantly influenced the risk of developing one or more post-operative
complications. Obesity, femoral neck (the uppermost section of the thigh bone) fracture, cardiac disease and diabetes significantly
increased the risk of developing major complications. The presence of shock following injury was the most important predictor
of both cardiac and venous thromboembolic disease complications with an odds ratio exceeding 10 for the development of cardiac
complications. "Most of the predictors of complications and mortality are non-modifiable," including the presence of significant cardiac/respiratory
disease, diabetes, dependence on dialysis and presentation to the hospital in shock, said Philip J.
Belmont, Jr., MD, an orthopaedic surgeon at the William Beaumont Army Medical Center in El
Paso, Texas, and the lead author of the study. "Reduced time to surgical intervention appears to be the single greatest factor with which a surgeon might influence the
risk of mortality or complications," said Dr. Belmont. A previous study has shown a 41 percent increase in mortality if surgery
is delayed 48 hours or more. The majority of patients are taken into surgery within 24 hours. In older hip fracture patients, the pre-operative "work-up," and/or the correction of major clinical abnormalities –
important and frequent considerations – can sometimes take more than one day, said Dr. Belmont. The potential benefit
of correcting major clinical abnormalities prior to hip fracture surgery can influence survival. This process often can be
expedited when the orthopaedic surgeon works directly with the internal medicine physician or hospitalist who is helping to
manage the patient. "With the rising incidence of hip fractures, patient-treatment solutions directed toward this modifiable factor may reduce
complications, and potentially, mortality," said Dr. Belmont.
View disclosure statement for Dr. Belmont
Follow us on Facebook.com/AAOS1 and Twitter.com/AAOS1
A Nation in Motion
For more information on bone and joint health, visit Orthoinfo.org. SOURCE American Academy of Orthopaedic Surgeons
|
|